Gossamer Bio, Inc. (GOSS)
0.38
+0.02
(+4.11%)
USD |
NASDAQ |
Apr 02, 15:14
Gossamer Bio Total Liabilities (Quarterly) : 295.01M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 161.76M |
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| Artelo Biosciences, Inc. | 4.073M |
| Axsome Therapeutics, Inc. | 601.51M |
| Crinetics Pharmaceuticals, Inc. | 143.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 172.25M |
| Shareholders Equity (Quarterly) | -122.76M |
| Debt to Equity Ratio | -1.653 |
| Current Ratio | 2.643 |
| Net Debt Paydown Yield | 0.02% |